Picture courtesy: ANI
New Delhi: With Serum Institute of India (SII)-manufactured Oxford University’s Covishield has been rolled out in India as first COVID-19 vaccine, there are four more waiting for approval from the authorities.
According to Union Health Secretary Rajesh Bhushan, Zydus Cadila, Sputnik V, Biological E and Gennova are currently in advanced clinical trials stage in India. “In the coming days you may see some of these vaccines too approaching the drug controller for emergency use authorisation,” Bhushan was quoted as saying by NDTV.
The Health Ministry said that there will be a 28-day gap between two doses of COVID-19 vaccine and its effectiveness will begin 14 days after the second dose. The health secretary said vaccine effectiveness can be seen only after 14 days. “So we urge people to keep following Covid-appropriate behaviour,” Bhushan said.
ALSO READ: Vaccine To Work After 14 Days Of 2nd Shot, No Option To Choose Between Covishield…
New Delhi: A fourth batch of Indian nationals deported from the US arrived at Indira… Read More
Berhampur: Rushikulya river mouth in Odisha’s Ganjam district has emerged as a major rookery for… Read More
Delhi/Mumbai: Twin tragedies in Delhi and Mumbai claimed the lives of a pair of 18-month-old… Read More
Jajpur: A total of 894 ineligible people fraudulently received benefits under an old-age pension scheme… Read More
Bhubaneswar: The International Conference on Recent Advances in Nanomedicine brought together more than 500 participants,… Read More
New Delhi: In a recent statement that has stirred political conversations, Shashi Tharoor reaffirmed his… Read More
This website uses cookies.